Neogenomics Inc stock is traded at $15.55, with a volume of 84,408. It is down -2.97% in the last 24 hours and down -6.64% over the past month. NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Previous Close:
$16.02
Open:
$15.75
24h Volume:
84,408
Relative Volume:
0.05
Market Cap:
$2.01B
Revenue:
$745.97M
Net Income/Loss:
-$99.21M
P/E Ratio:
-
EPS:
-$0.7729
Net Cash Flow:
-$5.09M
1W Performance:
-11.68%
1M Performance:
-6.64%
6M Performance:
+88.65%
1Y Performance:
+50.34%
1-Day Range:
$15.36$15.78
1-Week Range:
$15.36$17.67
52-Week Range:
$7.07$20.15
Neogenomics Inc Stock (NEO) Company Profile
Name
Neogenomics IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
(239) 768-0600Address
9490 NEOGENOMICS WAY, FORT MYERS, FL, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS